In some patients, the inflammatory‐immune response to surgical injury progresses to a
harmful, dysregulated state. We posit that postoperative systemic inflammatory dysregulation …

Background The glucocorticoid dexamethasone prevents nausea and vomiting after
surgery, but there is concern that it may increase the risk of surgical-site infection. Methods …

Objective To assess the effect of dexamethasone on complications or all cause mortality
after major non-cardiac surgery. Design Phase III, randomised, double blind, placebo …

Background Dexamethasone is commonly used for antiemesis in surgical patients. It has
been confirmed that long-term steroid use increases blood glucose level in both diabetic …

Background Dexamethasone is frequently used for the treatment of postoperative nausea
and vomiting and as an adjunct in multimodal postoperative analgesia after total joint …

Perioperative ADministration of Dexamethasone And blood Gluc... : European Journal of
Anaesthesiology | EJA Perioperative ADministration of Dexamethasone And blood Glucose …

Background Clinically significant postoperative nausea and vomiting (PONV) is a patient-
reported outcome which reflects patient experience. Although dexamethasone prevents …

Background. In a post hoc analysis of the ENIGMA-II trial, we sought to determine whether
intraoperative dexamethasone was associated with adverse safety outcomes. Methods …

Introduction The synthetic glucocorticoid dexamethasone is a commonly administered
antiemetic. It has immunosuppressive effects and may alter postoperative blood glucose …

Major bleeding in noncardiac surgery is common and associated with serious complications.
The antifibrinolytic agent tranexamic acid (TXA) reduces bleeding and may reduce the risk of …